You searched for "images"
Imaging papilloedema vs. pseudo-papilloedema
Quite often, in the working week as an ophthalmic photographer, you will be given that patient with ‘swollen discs’ to image. These swollen discs could be a number of things, but mainly fall into one of two categories: papilloedema or...Adaptive optics imaging: resolving single cells in the living eye
The human retina is unique in the central nervous system (CNS) in that it can be directly visualised non-invasively. Technological advances of several imaging modalities, including optical coherence tomography (OCT), multichannel scanning laser ophthalmoscopy (SLO) and fundus photography, have afforded...
Assessment and management of dry eye disease
This paper is an update on the assessment and management of dry eye disease (DED). According to the second International Dry Eye Workshop 2017, “Dry eye is a multifactorial disease of the ocular surface characterised by a loss of homoeostasis...Clinical relevance of the anatomic classification of neovascular age-related macular degeneration
The author explains why an OCT-based classification of neovascular AMD is needed and how these neovascular subtypes may help to predict patients’ long-term visual outcome. Age-related macular degeneration (AMD) is a chronic and progressive neurodegenerative process involving the macula in...Haag-Streit announces winners of Slit Lamp Imaging Competition 2023
Haag Streit is pleased to announce the release of the results of its Slit Lamp Imaging Competition 2023.
Vaughan and Asbury’s General Ophthalmology (19th edition)
Vaughan and Asbury’s General Ophthalmology (19th edition) is the latest update of this classic ophthalmology textbook that has been around for nearly 60 years. Written by British, American and Canadian authors, this book is intended for an international readership and...
Progression of macular atrophy on long-term anti-VEGF therapy for AMD
This retrospective study evaluated the progression of macular atrophy in 53 eyes of 53 patients receiving AntiVEGF Therapy for age-related macular degeneration (nAMD), for at least six years. None of the patients had any macular atrophy (MA) at presentation. MA...
